Clinical Trials Browser

Phase 2 × INDUSTRY × folfirinox × Clear all

NCT04589234 2024-04-24

Saltikva for Metastatic Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT01676259 2021-07-02

PROTACT

Phase 2 Unknown

Gastrointestinal

Neoplasms, Pancreatic Neoplasms